Vaestra Goetalandsregionen
- Address
- lock Available on a paid plan
Respiratory Tract Diseases
The research at Vastraa Goetalandsregionen includes respiratory tract diseases, with a focus on chronic obstructive pulmonary disease. These studies are designed to assess whether an existing treatment approach can help reduce flare-ups, lower serious health risks, and improve long-term outcomes for people living with COPD.
- Chronic obstructive pulmonary disease
- Prevention of exacerbations and related complications
- Evaluation of treatment benefit in patients without cardiovascular disease
At this hospital and clinic setting in Vänersborg, the work aims to better understand how supportive therapies may protect patients beyond symptom control.
Diseases of the Skin and Soft Tissue
This site is also involved in research on diabetic foot ulcer within nutritional and metabolic diseases. The trial activity is centered on improving wound healing and testing local antimicrobial treatments that may help ulcers close more effectively and reduce the burden of difficult-to-heal foot wounds.
- Diabetic foot ulcer
- Local antimicrobial treatment
- Support for faster and more complete healing
The studies reflect a practical effort to identify treatments that can improve recovery and quality of life for people with diabetes-related complications.
Nutritional and Metabolic Diseases
Clinical research in nutritional and metabolic diseases at Västragötalandsregionen includes type 2 diabetes. The main goal is to compare treatment options for people with early disease and determine which approach may better support disease control and longer-term health outcomes.
- Type 2 diabetes
- Early treatment strategies
- Comparing standard therapies for improved outcomes
This work is focused on helping clinicians choose effective care strategies that may slow progression and improve patient prognosis.
Bacterial Infections and Mycoses
Research in bacterial infections and mycoses at the site includes studies related to HPV infection and associated diseases such as cervical precancer and cervical cancer. The aim is to evaluate whether combining vaccination and screening can help eliminate infection more rapidly at the population level.
- HPV infection and related cervical disease
- Cervical intraepithelial neoplasia
- Prevention and early elimination strategies
These studies support public health efforts by examining how organised prevention programs may strengthen control of infection and reduce the future burden of cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 13 of 14 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1AbbVie Deutschland GmbH & Co. KG2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AbbVie Deutschland GmbH & Co. KG2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vaestra Goetalandsregionen
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 years of age with Migraine | AbbVie Deutschland GmbH & Co. KG | Phase III | Recruiting | Dec 2023 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atogepant | 2 | Unknown | 2023-11-08 | 2023-12-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.